WION Fineprint: How effective is blood-thinning therapy for COVID patients?

According to a new study, the blood-thinning drug Apixaban puts patients at risk for no clear benefit. The drug has been used as a potential life-saver for those recovering from severe COVID-19. But the research suggests that it does not work and can cause major bleeding. Molly Gambhir brings you the details.